Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs

Inhibiting thrombosis without inducing bleeding is a major challenge for anticoagulant agents. Here the authors describe a synthetic FXIIa inhibitor able to efficiently prevent thrombosis in mice and suppress coagulation in artificial lungs in rabbits without increasing the risk of bleeding.

Guardado en:
Detalles Bibliográficos
Autores principales: Jonas Wilbs, Xu-Dong Kong, Simon J. Middendorp, Raja Prince, Alida Cooke, Caitlin T. Demarest, Mai M. Abdelhafez, Kalliope Roberts, Nao Umei, Patrick Gonschorek, Christina Lamers, Kaycie Deyle, Robert Rieben, Keith E. Cook, Anne Angelillo-Scherrer, Christian Heinis
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/1f9ddb75be1e4a398c1ff63698dcaa1b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1f9ddb75be1e4a398c1ff63698dcaa1b
record_format dspace
spelling oai:doaj.org-article:1f9ddb75be1e4a398c1ff63698dcaa1b2021-12-02T18:49:31ZCyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs10.1038/s41467-020-17648-w2041-1723https://doaj.org/article/1f9ddb75be1e4a398c1ff63698dcaa1b2020-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-17648-whttps://doaj.org/toc/2041-1723Inhibiting thrombosis without inducing bleeding is a major challenge for anticoagulant agents. Here the authors describe a synthetic FXIIa inhibitor able to efficiently prevent thrombosis in mice and suppress coagulation in artificial lungs in rabbits without increasing the risk of bleeding.Jonas WilbsXu-Dong KongSimon J. MiddendorpRaja PrinceAlida CookeCaitlin T. DemarestMai M. AbdelhafezKalliope RobertsNao UmeiPatrick GonschorekChristina LamersKaycie DeyleRobert RiebenKeith E. CookAnne Angelillo-ScherrerChristian HeinisNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-13 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Jonas Wilbs
Xu-Dong Kong
Simon J. Middendorp
Raja Prince
Alida Cooke
Caitlin T. Demarest
Mai M. Abdelhafez
Kalliope Roberts
Nao Umei
Patrick Gonschorek
Christina Lamers
Kaycie Deyle
Robert Rieben
Keith E. Cook
Anne Angelillo-Scherrer
Christian Heinis
Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
description Inhibiting thrombosis without inducing bleeding is a major challenge for anticoagulant agents. Here the authors describe a synthetic FXIIa inhibitor able to efficiently prevent thrombosis in mice and suppress coagulation in artificial lungs in rabbits without increasing the risk of bleeding.
format article
author Jonas Wilbs
Xu-Dong Kong
Simon J. Middendorp
Raja Prince
Alida Cooke
Caitlin T. Demarest
Mai M. Abdelhafez
Kalliope Roberts
Nao Umei
Patrick Gonschorek
Christina Lamers
Kaycie Deyle
Robert Rieben
Keith E. Cook
Anne Angelillo-Scherrer
Christian Heinis
author_facet Jonas Wilbs
Xu-Dong Kong
Simon J. Middendorp
Raja Prince
Alida Cooke
Caitlin T. Demarest
Mai M. Abdelhafez
Kalliope Roberts
Nao Umei
Patrick Gonschorek
Christina Lamers
Kaycie Deyle
Robert Rieben
Keith E. Cook
Anne Angelillo-Scherrer
Christian Heinis
author_sort Jonas Wilbs
title Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
title_short Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
title_full Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
title_fullStr Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
title_full_unstemmed Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
title_sort cyclic peptide fxii inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/1f9ddb75be1e4a398c1ff63698dcaa1b
work_keys_str_mv AT jonaswilbs cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT xudongkong cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT simonjmiddendorp cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT rajaprince cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT alidacooke cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT caitlintdemarest cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT maimabdelhafez cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT kallioperoberts cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT naoumei cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT patrickgonschorek cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT christinalamers cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT kayciedeyle cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT robertrieben cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT keithecook cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT anneangelilloscherrer cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
AT christianheinis cyclicpeptidefxiiinhibitorprovidessafeanticoagulationinathrombosismodelandinartificiallungs
_version_ 1718377548390334464